242: Pharmacogenetics Determinants of Anticancer Activity of Intravescical Gemcitabine in Patients with Superficial Transitional Cell Carcinoma (TCC) of The Bladder

Autor:	D. Matel Victor, Umberto Besana, Bernardo Rocco, Marcelo Pimentel, Gennaro Musi, E. Scardino, Giuseppe Curigliano, de Cobelli Ottavio, Sara Nanizzi, Elisa Giovanetti, de Braud Filippo, Romano Danesi, Gianluca Spitaleri, Eduardo Pedroso, F. Verweij, Stefano Zambito, Salvatore Pece, Valentina Mey
Rok vydání:	2007
Předmět:	Transitional cell carcinoma business.industry Urology Cancer research Medicine In patient business medicine.disease Pharmacogenetics Gemcitabine medicine.drug
Zdroj:	Journal of Urology. 177:81-81
ISSN:	1527-3792 0022-5347
DOI:	10.1016/s0022-5347(18)30507-x
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::f853d1bbeb1f05018fe6479038902193 https://doi.org/10.1016/s0022-5347(18)30507-x Zobrazit plný text záznamu